Navigation Links
Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
Date:5/18/2009

Schering-Plough Assumes Exclusive Worldwide Marketing Rights for Mometasone Furoate/Formoterol Combination for Asthma and COPD

KENILWORTH, N.J., May 19 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced changes to its global collaboration with Novartis for the development and commercialization of fixed-dose combination therapies for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The changes will result in Schering-Plough assuming exclusive worldwide rights to develop and commercialize a fixed-dose combination of its inhaled corticosteroid ASMANEX(R) (mometasone furoate inhalation powder), and Novartis' long-acting beta2-adrenergic receptor agonist, FORADIL(R) (formoterol fumarate). Also as a result, Novartis will assume exclusive worldwide rights to develop and commercialize a fixed-dose combination of Schering-Plough's inhaled corticosteroid mometasone furoate with its investigational beta2-agonist QAB149 (indacaterol).

"Schering-Plough has a long history in developing therapies for treating respiratory diseases. This strategic action will allow us to focus our efforts within the asthma and COPD market," said Thomas P. Koestler, Ph.D., executive vice president and president, Schering-Plough Research Institute. "The investigational fixed-dose combination of ASMANEX and FORADIL, both of which are currently approved and marketed as individual products, is in Phase III development for the treatment of asthma and COPD. Schering-Plough anticipates filing the mometasone furoate/formoterol combination for the treatment of asthma with the Food and Drug Administration in the first half of 2009," added Koestler.

This is the latest development in a successful long-term relationship between Novartis and Schering-Plough which dates back to 2002. The collaboration was
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Schering-Plough Schedules Webcast For Annual Meeting of Shareholders
2. Schering-Plough Schedules Conference Call Webcast for 2009 First Quarter Earnings
3. Schering-Plough to Webcast Presentation at Barclays Capital Global Healthcare Conference
4. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
5. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
6. Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries
7. Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
8. Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
9. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
10. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
11. Schering-Plough Reschedules Time of Conference Call, Webcast for 2008 Second Quarter Earnings to Later Today

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...IEGO,Nov.24,2009/PRNewswire-FirstCall/--ArenaPharm...thecompanyisscheduledtopresentatthePiperJaffray21s...a.m.EasternTime(8:30a.m.PacificTime)attheNewYorkPa...andChiefExecutiveOfficer,isscheduledtoprovideanove...nddiscoveryprograms. ,, Aliveaudiowebcastofthep...
(Date:11/24/2009)... Program Connects Customers with Part...ected with DNA Genotek Products , ...DNA Genotek , a leading provider of products for b...paration, today announced its new global partner p...s for DNA Genotek,s partner community and is desig...
(Date:11/23/2009)... CITY, Nov. 23, 2009 In a provocative new study, ...carbon dioxide emissions the major cause of globa... economy collapses or society builds the equivalen...t looks unlikely that there will be any substantia...eration in carbon dioxide emission rates," says th...
(Date:11/23/2009)...onsists of a two-dimensional carbon layer in which...ice, resembling a honeycomb. Carbon nanotubes are ...raphene sheets form graphite. Graphene boasts some...r-resistant, an excellent thermal conductor, and r...s and ductility. In addition, graphene is impermea...
Breaking Biology Technology:Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4Polymer with honeycomb structure 2
...une 26 ,Oridion Systems Ltd. - (SWX: ORIDN) Oridio...of innovative capnography monitoring solutions, an...ship Award from IMDA, the,association of medical s...award, IMDA acknowledges the Company,s achievement...ty distributors (part of the Oridion Distribution,...
...wire-FirstCall/ --,China-Biotics, Inc. (OTC Bullet...a leading Chinese firm specializing in the manufac...tion of probiotics products,today announced it sig...eutical Co., Ltd. ("Lijia") to supply probiotics f... both powder and tablet forms. The,agreement runs ...
... Shock Congress by sepsis thought ...wire-FirstCall/ - Spectral Diagnostics Inc.,(TSX: ... demonstrates the,combined clinical effectiveness ... FDA cleared diagnostic for the measurement of end...in levels and to guide endotoxin,reducing strategi...
Other Biology Technology:Oridion Wins 2008 Manufacturers Partnership Award From Independent Medical Distributor's Association 2Oridion Wins 2008 Manufacturers Partnership Award From Independent Medical Distributor's Association 3Oridion Wins 2008 Manufacturers Partnership Award From Independent Medical Distributor's Association 4China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company 2China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company 3Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics 2
(Date:11/23/2009)...research suggests that a common oral bacterium may...t by Nichols et al, "Unique Lipids from a Common H...ds Capable of Enhancing Autoimmunity," appears in ...f Pathology . , Multiple sclerosis (MS), a disea...pinal cord, affects nearly 1 in 700 people in the ...
(Date:11/23/2009)...swine vaccine available for the H1N1 virus has bee... virus. The vaccination marks the first time vacci...e pandemic flu., Iowa State University,s Hank Ha...accine this summer and has been shipping preventiv...inois for several weeks., The latest vaccines we...
(Date:11/23/2009)..., 2009 -- A USDOE and USDA study concluded that 50...d cropland pasture could be converted from current... as switchgrass, from which biomass could be harve...viable production of a perennial grass monoculture...removed annually is expected to require nitrogen f...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 1Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 2Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 3Allsup Outlines Role of Social Security Disability Insurance for Obtaining Medicare Benefits 56509 4First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 1First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 2First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 3Work conditions impact parents food choices 9834 1Work conditions impact parents food choices 9834 2
...icist at The University of Texas Health Science Ce... 4,000 people in the hopes of finding out why bloo... The two-year study by principal investigator Myri...on grant from the Genes, Environment and Health In...h. The grant was one of six announced today during...
... (Sept. 24, 2008) Self-guided treatment for depr...Scientists with the National Space Biomedical Rese...ve, multi-media program that will assist astronaut...on and other psychosocial problems, which can pose...perations during long-duration spaceflights. , E...
...chers at the University of Bath and conservationis...19 birds on Salisbury Plain on Thursday 25 Septemb... the UK. , The globally threatened Great Bustard ...o habitat loss and hunting became extinct in the U...s, researchers in the Department of Biology & Bioc...
Other Biology News:Scientist plans to test for blood pressure genes affected by age 2Coming soon: Self-guided, computer-based depression treatment 2Coming soon: Self-guided, computer-based depression treatment 3
Rabbit Anti-Porcine Vitronectin Antibody, Unconjugated from Cosmo Bio Co., Ltd.
...n with Pall Life Sciences to offer Automation Cert...e chemistries. The Automation Certified filters ar..., Prelude, and Benchmate instruments. Detailed Spe...ed Syringe Filters are available at our Partner Si...
Rabbit Anti-BMP2 Polyclonal Antibody, Unconjugated from GeneTex
Microseal 384 Plate Positioner from Bio-Rad
Biology Products: